| Jazz Pharmaceuticals, Inc. | 8 | $181,969 | $169,754 – $188,157 |
| Gilead Sciences, Inc. | 3 | $167,107 | $152,162 – $167,274 |
| Agios Pharmaceuticals, Inc. | 2 | $192,500 | $191,250 – $193,750 |
| Eisai Inc. | 2 | $185,000 | $185,000 – $185,000 |
| Organon LLC | 2 | $116,542 | $104,416 – $128,669 |
| Sarepta Therapeutics, Inc. | 2 | $179,000 | $179,000 – $179,000 |
| Symbiance Inc. | 2 | $120,000 | $120,000 – $120,000 |
| Sutro Biopharma, Inc. | 2 | $205,430 | $205,394 – $205,465 |
| Takeda Development Center Americas, Inc. | 2 | $195,180 | $194,090 – $196,269 |
| Keros Therapeutics | 2 | $180,000 | $180,000 – $180,000 |
| Dyne Therapeutics, Inc. | 2 | $207,500 | $206,250 – $208,750 |
| uniQure, Inc. | 2 | $191,000 | $179,000 – $203,000 |
| Exelixis, Inc. | 1 | $220,000 | $220,000 – $220,000 |
| Daiichi Sankyo, Inc. | 1 | $176,144 | $176,144 – $176,144 |
| CSL Behring L.L.C. | 1 | $192,000 | $192,000 – $192,000 |
| Cytel Inc. | 1 | $152,565 | $152,565 – $152,565 |
| Corcept Therapeutics, Inc | 1 | $215,000 | $215,000 – $215,000 |
| AstraZeneca Pharmaceuticals LP | 1 | $155,000 | $155,000 – $155,000 |
| Alnylam US, Inc. | 1 | $225,000 | $225,000 – $225,000 |
| Apellis Pharmaceuticals Inc. | 1 | $220,743 | $220,743 – $220,743 |
| Allucent Government Services (US) LLC | 1 | $174,292 | $174,292 – $174,292 |
| Novartis Pharmaceuticals Corporation | 1 | $145,454 | $145,454 – $145,454 |
| Intra-Cellular Therapies, Inc. | 1 | $165,860 | $165,860 – $165,860 |
| Iovance Biotherapeutics, Inc. | 1 | $156,499 | $156,499 – $156,499 |
| Generate Biomedicines, Inc. | 1 | $195,000 | $195,000 – $195,000 |
| Kardigan, Inc. | 1 | $183,000 | $183,000 – $183,000 |
| Regeneron Pharmaceuticals, Inc. | 1 | $215,454 | $215,454 – $215,454 |
| Pharmaceutical Research Associates, Inc. | 1 | $181,011 | $181,011 – $181,011 |